A Study to Assess the Safety and Immunogenicity of the Drug CAT-354 in Healthy Japanese Subjects

This study has been completed.

Sponsor:

Collaborators:

MedImmune Ltd

AstraZeneca

Information provided by (Responsible Party):

MedImmune LLC

ClinicalTrials.gov Identifier:

NCT01093040

First received: March 19, 2010

Last updated: August 29, 2012

Last verified: August 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2010
Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)